Evidence map›Paper›PMID 36595455›Full record

SynthesisExperimental and clinical psychopharmacology2023

Applications of isradipine in human addiction studies: A systematic literature review.

Samantha Natal, Cara C Young, Karamveer Kaur, Eli S Gebhardt, Alexander Perrone, Hitoshi Morikawa, Carlos Tirado, Jasper A J Smits

Open access · hybridAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Experimental and clinical psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Samantha NatalDepartment of Psychology, University of Texas at Austin.
Cara C YoungSchool of Nursing, University of Texas at Austin.ORCID 0000-0001-6599-7145
Karamveer KaurDepartment of Psychology, University of Texas at Austin.
Eli S GebhardtDepartment of Psychology, University of Texas at Austin.
Alexander PerroneDepartment of Psychology, University of Texas at Austin.
Hitoshi MorikawaDepartment of Neuroscience, University of Texas at Austin.
Carlos TiradoSchool of Pharmacy, University of Texas at Austin.
Jasper A J SmitsDepartment of Psychology, University of Texas at Austin.ORCID 0000-0003-1633-9693
The University of Texas at Austin · USAustin College · US

Funding

Isradipine and Virtual Reality Cue Exposure for Smoking CessationR21DA049539 · NIDA · UNIVERSITY OF TEXAS AT AUSTIN · PI SMITS, JASPER, YOUNG, CARA CALLOWAY · 2019 to 2020
$430k
NIDA NIH HHS R21 DA049539
6 · The paper itself

Abstract

Given the personal and public health burden of addictive disorders, innovative approaches to treatment are sorely needed. This systematic review examined the use of the pharmacological agent isradipine in the context of potential applications for addiction treatment. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guided a comprehensive search of PubMed, Cochrane Library, and PsycINFO between the years 1985 to July 2022. Studies were included if isradipine was administered to adults with a current

Indexed as

CocaineMethamphetamineSubstance-Related DisordersAdultCalcium Channel BlockersHumansIsradipineCalcium Channel BlockersCocaineIsradipineMethamphetamine

Identifiers

PMID36595455
PMCPMC10152997
OpenAlexW4313454885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.